Loading...

NDRA ENDRA LIFE SCIENCES INC Capital Structure Changes 8-K Filing

NDR

NDR

ENDRA LIFE SCIENCES INC

(NDRA)

2025 8-K

Financial Results Release

Strategic Review Initiated

Stockholder Approvals

Management Changes

Regaining Compliance

Stock Offering Agreement

Digital Asset Launch

Technical Correction

Fundraising Announcement

Cryptocurrency Treasury Str...

Equity Offerings

Investor Meetings

Failure to Maintain Listing...

Financial Statements

Financial Results

Nasdaq Compliance

Financial Results

Stock Split Approval

Nasdaq Compliance Extension

CEO Resignation

Management Changes

Agreement for Stock and War...

Financial Results Announcement

Results of Operations and F...

Financial Results Announcement

Financial Results Announcement

Financial Results and FDA A...

Annual Meeting Results

Meeting Adjournment

Financial Results Announcement

Underwriting Agreement

Financial Results

Financial Results Announcement

External Links:

ENDRA Life Sciences Inc. filed an 8-K report on November 14, 2025, updating that it has likely regained compliance with Nasdaq's $2.5 million stockholders' equity requirement after raising approximately $4.9 million through a private placement on October 15, 2025.

AI Assistant

ENDRA LIFE SCIENCES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.